DRG International to present Aldosterone ELISA Kit at 2016 AACC

DRG International, a leading international medical diagnostic company, will showcase its DRG® Aldosterone ELISA Kit at the 2016 AACC in Philadelphia, Pennsylvania on August 02-04. The DRG International Aldosterone ELISA is for measurement of Aldosterone in serum, plasma, and urine.

Aldosterone regulates levels of sodium and potassium in the body and also controls blood pressure as well as fluids and electrolytes in the blood. Measurement of aldosterone levels in serum in conjunction with plasma renin levels (aldosterone/renin-ratio; ARR) can be used to differentiate between primary and secondary aldosteronism. The differentiation is vital in the treatment and management of the disease.

"The importance of testing Aldosterone is growing in the research and clinical communities," said Dr. Cyril E. Geacintov, founder, president and CEO of DRG International. "The accuracy and ease of use of this kit make it a top choice of researchers world-wide."

The DRG® Aldosterone ELISA Kit is an exciting addition to the laboratory field. It is a solid phase enzyme-linked immunosorbent assay (ELISA) based on the competitive principle. The Aldosterone ELISA Kit is available globally, and for research use only in the United States.

DRG International will be showcasing at the AACC in Booth 3713. Press inquiries are welcome. For more information, please contact Gregory Guest (International Marketing Manager for DRG International) at (973) 564-7555.

Source:

2016 AACC Annual Meeting Press Program

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood count stability reveals new pathways to personalized care